• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,499.17 129.78
(0.25%)
Dow Jones
7,562.80 59.09
(0.79%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Orient Electric Ltd
Industry :  Domestic Appliances
BSE Code
ISIN Demat
Book Value()
541301
INE142Z01019
35.6240896
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ORIENTELEC
35.85
3686.96
EPS(TTM)
Face Value()
Div & Yield %
4.82
1
0.87
 

stanrose mafatlal investment & finance ltd
Orchid Pharma rises after Q4 net profit increases 7% to Rs 24 crore
May 26,2026
Revenue from operations rose marginally to Rs 237.61 crore in Q4 FY26 as against Rs 237.48 crore posted in the same period last year.

Profit before exceptional items and tax stood at Rs 22.25 crore, up 16.55% from Rs 19.09 crore reported in Q4 FY25. The company reported exceptional items of Rs 0.54 crore during the quarter.

For the full financial year FY26, the company reported a 79.37% decline in consolidated net profit to Rs 20.55 crore, while revenue from operations fell 11.99% year-on-year to Rs 811.33 crore compared with FY25.

Orchid Pharma is a Chennai-based pharmaceutical company engaged in the development, manufacture and marketing of bulk actives, formulations and nutraceuticals, with exports to over 40 countries.